drugset / Trial / NCT05043350
Combined Antihistaminics Therapy in COVID 19 Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
The use of antihistaminic medications could result in a significant immune modulation which may help in the treatment of cytokine storm of COVID-19.Thus, the aim of this study is to evaluate efficacy and safety of famotidine and loratadine combination in covid 19 treatment protocol.
Timeline
- Start
- 2021-09-13
- Primary completion
- 2022-07-30
- Completion
- 2022-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Loratadine | Small molecule | 10 mg | Oral |
| Background | Famotidine | Other / unclassified | 40 mg | Intravenous |